A quantitative systems physiology model of renal function and blood pressure regulation: Application in salt-sensitive hypertension

CPT: Pharmacometrics and Systems Pharmacology

Volumn 6, Issue 6, 2017, Pages 393-400

  Hallow, K M ^a   Gebremichael, Y ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT; DIURETIC AGENT;

ARTICLE; BLOOD PRESSURE REGULATION; GLOMERULUS FILTRATION RATE; HUMAN; HYDROSTATIC PRESSURE; HYPERTENSION; KIDNEY FUNCTION; KIDNEY TUBULE ABSORPTION; PRIORITY JOURNAL; SALT INTAKE; SIMULATION; SODIUM ABSORPTION; SODIUM EXCRETION; VALIDATION STUDY; BIOLOGICAL MODEL; BLOOD PRESSURE; DRUG EFFECTS; KIDNEY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DIURETICS; HUMANS; HYPERTENSION; KIDNEY; MODELS, BIOLOGICAL; SODIUM CHLORIDE, DIETARY;

EID: 85019900323     PISSN: None     EISSN: 21638306     Source Type: Journal    
DOI: 10.1002/psp4.12177     Document Type: Article

References (35)

1. Campese, V.M. & Karubian, F. Salt sensitivity in hypertension: implications for the kidney. J. Am. Soc. Nephrol. 2(2 suppl. 1), S53-61 (1991).
2. Elijovich, F. et al. Salt sensitivity of blood pressure: a scientific statement from the American Heart Association. Hypertension 68, e7-e46 (2016).
3. Campese, V.M., Parise, M., Karubian, F. & Bigazzi, R. Abnormal renal hemodynam-ics in black salt-sensitive patients with hypertension. Hypertension 18, 805-812 (1991).
4. Tuck, M., Corry, D. & Trujillo, A. Salt-sensitive blood pressure and exaggerated vascular reactivity in the hypertension of diabetes mellitus. Am. J. Med. 88, 210-216 (1990).
5. Weinberger, M.H., Miller, J.Z., Luft, F.C., Grim, C.E. & Fineberg, N.S. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 8, II127-134 (1986).
6. Luft, F.C. et al. Salt sensitivity and resistance of blood pressure. Age and race as factors in physiological responses. Hypertension 17, I102-108 (1991).
7. Cheng, Z.J. et al. Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats. Hypertension 37, 433-439 (2001).
8. Collins, A.J. et al. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am. J. Kidney Dis. 59, A7e1-420 (2012).
9. Chrysant, S.G. et al. Effects of isradipine or enalapril on blood pressure in salt-sensitive hypertensives during low and high dietary salt intake. MIST II Trial Investigators. Am. J. Hypertens. 13, 1180-1188 (2000).
10. Materson, B.J. et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N. Engl. J. Med. 328, 914-921 (1993).
11. Hallow, K.M. & Gebremichael, Y. A quantitative systems physiology model of renal function and blood pressure regulation: model description. CPT Pharmacometrics Syst. Pharmacol. (2017) (in press).
12. Anderson, S., Meyer, T.W. & Brenner, B.M. The role of hemodynamic factors in the initiation and progression of renal disease. J. Urol. 133, 363-368 (1985).
13. Neuringer, J.R. & Brenner, B.M. Glomerular hypertension: cause and consequence of renal injury. J. Hypertens. Suppl. 10, S91-97 (1992).
14. Granger, J.P., Alexander, B.T. & Llinas, M. Mechanisms of pressure natriuresis. Curr. Hypertens. Rep. 4, 152-159 (2002).
15. Garcia-Estan, J. & Roman, R.J. Role of renal interstitial hydrostatic pressure in the pressure diuresis response. Am. J. Physiol. 256, F63-70 (1989).
16. O'Connor, P.M. & Cowley, AW, Jr. Modulation of pressure-natriuresis by renal medullary reactive oxygen species and nitric oxide. Curr. Hypertens. Rep. 12, 86-92 (2010).
17. Haas, J.A., Khraibi, A.A., Perrella, M.A. & Knox, F.G. Role of renal interstitial hydrostatic pressure in natriuresis of systemic nitric oxide inhibition. Am. J. Physiol. 264, F411-414 (1993).
18. Barba, G. et al. Renal function and blood pressure response to dietary salt restriction in normotensive men. Hypertension 27, 1160-1164 (1996).
19. Khan, J.M. & Beevers, D.G. Management of hypertension in ethnic minorities. Heart 91, 1105-1109 (2005).
20. Sehgal, A.R. Overlap between whites and blacks in response to antihypertensive drugs. Hypertension 43, 566-572 (2004).
21. Anderson, W.P. et al. Renovascular hypertension: structural changes in the renal vas-culature. Hypertension 36, 648-652 (2000).
22. Hallow, K.M. et al. A model-based approach to investigating the pathophysiological mechanisms of hypertension and response to antihypertensive therapies: extending the Guyton model. Am. J. Physiol. Regul. Integr. Comp. Physiol. 306, R647-662 (2014).
23. Shirato, I., Hishiki, T. & Tomino, Y. Podocyte loss and progression of diabetic nephropathy. Contrib. Nephrol. 69-73 (2001).
24. O'Bryan, G.T. & Hostetter, T.H. The renal hemodynamic basis of diabetic nephropa-thy. Semin. Nephrol. 17, 93-100 (1997).
25. Krikken, J.A., Laverman, G.D. & Navis, G. Benefits of dietary sodium restriction in the management of chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 18, 531-538 (2009).
26. Weir, M.R., Dengel, D.R., Behrens, M.T. & Goldberg, A.P. Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. Hypertension 25, 1339-1344 (1995).
27. Wright, F.S. & Schnermann, J. Interference with feedback control of glomerular filtration rate by furosemide, triflocin, and cyanide. J. Clin. Investig. 53, 1695-1708 (1974).
28. Roush, G.C. & Sica, D.A. Diuretics for hypertension: a review and update. Am. J. Hypertens. 29, 1130-1137 (2016).
29. Sarafidis, P.A., Khosla, N. & Bakris, G.L. Antihypertensive therapy in the presence of proteinuria. Am. J. Kidney Dis. 49, 12-26 (2007).
30. Averina, V.A., Othmer, H.G., Fink, G.D. & Osborn, J.W. A new conceptual paradigm for the haemodynamics of salt-sensitive hypertension: a mathematical modelling approach. J. Physiol. 590, 5975-5992 (2012).
31. Laffer, C.L., Scott, R.C., 3rd, Titze, J.M., Luft, F.C. & Elijovich, F. Hemodynamics and salt-and-water balance link sodium storage and vascular dysfunction in salt-sensitive subjects. Hypertension 68, 195-203 (2016).
32. Hallow, K.M. Mathematical model of renal hemodynamic and structural consequences of increased proximal sodium reabsorption in early diabetic kidney disease. FASEB J. 29, (2015).
33. Vallon, V., Richter, K., Blantz, R.C., Thomson, S. & Osswald, H. Glomerular hyperfil-tration in experimental diabetes mellitus: potential role of tubular reabsorption. J. Am. Soc. Nephrol. 10, 2569-2576 (1999).
34. Vallon, V. & Thomson, S.C. Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney. Annu. Rev. Physiol. 74, 351-375 (2012).
35. Wanner, C. et al. Empagliflozin and progression of kidney disease in type 2 diabetes. N. Engl. J. Med. 375, 323-334 (2016).